- In a new report, Citron Research assigns a $56 near-term PT to 3D Systems (DDD -6.5%), and takes aim at the company's valuation (naturally), growth prospects, and competitive positioning.
- Citron doesn't believe any of the companies 3D has acquired "control transformative technologies" amid a fragmented IP environment for 3D printing, and deems its Cube consumer/enthusiast 3D printer line to be second-rate.
- As evidence, it notes a Cube printer has an average rating of just 2.6/5 on Amazon from 10 reviewers, while MakerBot's (SSYS -4.7%) competing Replicator 2 has a rating of 3.8/5 from 48 reviewers.
- Citron also notes recently-acquired Phenix Systems (represents 3D's entry into the metal printing market) has had less than $10M in revenue each of the last four years, and makes note of pending competition from Mitsubishi, H-P, and Epson. Likewise, The Sugar Lab (acquired in September) is deemed to be "nothing more than a husband and wife team working out an apartment in East Los Angeles."
- Like Credit Suisse, Citron notes 3D trades at a major premium to Stratasys, which it considers a relatively better investment, and thinks shares would only be worth $46 even if 3D generated $2B in 2021 sales with a 20% profit margin, and paid no taxes.
- Stratasys has followed 3D lower, as have Voxeljet (VJET -5.8%) and ExOne (XONE -6.8%).
- Previous: Citron calls 3D a "bubble stock"
From other sites
at Nasdaq.com (Apr 10, 2015)
at Investopedia (Apr 8, 2015)
at Zacks.com (Apr 7, 2015)
3D Systems : Introduces Groundbreaking Virtual Medical Training Solutions for Advanced Care and Improved Patient Outcomesat 4-traders.com (Mar 23, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs